GV

GeezerVison

The World Wide Web, restored to 800 pixels of glory.

Home|About|Gaming cabinet|Archives|How it works|Starter sites

On this site

  • Patients
  • Treating cancerWhat are my treatment options?
  • Guiding prenatal careAm I having a boy or girl?
  • Genetic testing cost
  • NIPT and prenatal genetic testing cost
  • Billing
  • Financial assistance
  • Disease information
  • Patient record request
  • Documents & forms
  • Blood draw locator
  • Blog
  • What are my treatment options?
  • What is a pregnancy’s risk of a genetic disease?

This view

  • Original page
  • New address

GeezerVison is showing myriad.com — Gene Table | Myriad Genetics

Gene Table

Unable to load the gene table right now. Please try again later.

  • Associated Genes

  • Associated Syndromes

Print gene table Print syndromes table
  • Genes Breast Ovarian Colorectal Uterine Skin Pancreatic Gastric Prostate Renal Lung Endocrine Other
  • Genes Breast Ovarian Colorectal Uterine Skin Pancreatic Gastric Prostate Renal Lung Endocrine Other

In addition to the genes listed above, Myriad Genetics MyRisk® Hereditary Cancer Test includes RiskScore® Assessment, a precision medicine tool that predicts a woman’s five year and lifetime risk for developing breast cancer. RiskScore analyzes over 385 validated genetic and risk markers combined with the Tyrer-Cuzick model to estimate a woman’s risk for developing breast cancer.

RiskScore is calculated for women under age 85 without a personal history of breast cancer, LCIS, hyperplasia, atypical hyperplasia, or a breast biopsy with unknown results. RiskScore is not calculated if the patient is known to carry a mutation in a breast cancer risk gene other that CHEK2, or if there are any known mutations in high-penetrance breast cancer risk genes in the patient’s family.

To learn more about RiskScore assessment and the medical management guidelines provided for patients identified to have a remaining lifetime risk of breast cancer >20%, you may view the result insert by clicking the link below.

View RiskScore Insert

Genes selected for MyRisk satisfy these criteria:

  • Cancer Focus
    • Heritable contribution
    • Association with overlapping syndromes
  • Penetrance
    • Cancer risk is at least 2-3 times the general population
  • Clinically Significant
    • Based on increased cancer risk from societal guidelines or determined by multiple studies
    • Change in management inferred based on risk level

Each gene tested with the MyRisk Test links to one or more of 11 cancer sites:
Breast, Ovarian, Colorectal, Uterine, Skin, Pancreatic, Gastric, Prostate, Renal, Lung, and Endocrine.

The MyRisk Test simplifies the test selection process by providing you the most comprehensive hereditary cancer panel test with clinically significant results. Rest assured you’re testing for the most clinically significant genes tied to your patients’ risk.

Powerful tests to illuminate life-changing insights

  • Identifies risk of developing 11 hereditary cancers

    Learn more

  • Identifies actionable genomic variants and biomarkers associated with FDA-approved therapies

    Learn more

  • Identifies HRD status to inform treatment strategies

    Learn more

  • Identifies prostate cancer aggressiveness to inform treatment strategies

    Learn more

  • Identifies risk of developing 11 hereditary cancers leveraging family history of certain cancers

    Learn more

  • Identifies at-risk couples for a pregnancy affected by inherited conditions

    Learn more

  • Identifies risk of chromosomal conditions for expectant parents

    Learn more

  • Identifies fetal sex as early as six weeks into pregnancy

    Learn more

  • Identifies how genes affect outcomes with certain mental health medications

    Learn more
    You are visitor 01402503 — GeezerVison does not store the pages you look up.
    Best viewed with Netscape Navigator 4.7 or Internet Explorer 6 at 800×600. No cookies required.